The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Adams Eric A since 2021.
This trader's CIK number is 1817882.
At the time of last reporting, Adams Eric A was the President & CEO of Inmed Pharmaceuticals Inc.. (stock ticker symbol INM).
Also see all insider trading activities at Inmed Pharmaceuticals Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | INM | 41,600 | $14,934 | 0 | $0 | 0 | $0 |
| 2022 | INM | 22,720 | $19,935 | 0 | $0 | 0 | $0 |
| 2021 | INM | 20,200 | $35,208 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-02-20 | INM | Buy | 41,600 | .36 | 14,934 |
| 2022-04-14 | INM | Buy | 14,160 | .89 | 12,659 |
| 2022-04-13 | INM | Buy | 8,560 | .85 | 7,276 |
| 2021-09-29 | INM | Buy | 8,800 | 1.73 | 15,224 |
| 2021-09-28 | INM | Buy | 11,400 | 1.75 | 19,984 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Adams Eric A (President & CEO of Inmed Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.